Viridian Therapeutics Announces Pricing of $251 Million Public Offering of Shares of Common Stock

Core Viewpoint - Viridian Therapeutics, Inc. has announced the pricing of an underwritten public offering of its common stock, indicating a strategic move to raise capital for its operations in the biotechnology sector [1] Company Summary - Viridian is offering a total of 11,425,000 shares of common stock at a public offering price of $22.00 per share, which reflects the company's efforts to secure funding for the development of medicines targeting serious and rare diseases [1] - The company has granted underwriters a 30-day option to purchase additional shares, which could further enhance the capital raised through this offering [1]